Cargando…
Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain
Introduction: Transporters comprising the blood-brain barrier complicate delivery of many therapeutics to the central nervous system. The present study ascertained whether the natural product botryllamide G is viable for in vivo inhibition of ABCG2 using lapatinib as a probe for ABCB1 and ABCG2-medi...
Autores principales: | Strope, Jonathan D., Peer, Cody J., Sissung, Tristan M., Hall, O. Morgan, Huang, Phoebe A., Harris, Emily M., Gustafson, Kirk R., Henrich, Curtis J., Sigano, Dina M., Pauly, Gary T., Schneider, Joel P., Bates, Susan E., Figg, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012088/ https://www.ncbi.nlm.nih.gov/pubmed/31709896 http://dx.doi.org/10.1080/15384047.2019.1683324 |
Ejemplares similares
-
Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted
por: Sissung, Tristan M., et al.
Publicado: (2022) -
Precision medicine applications in prostate cancer
por: McCrea, Edel M., et al.
Publicado: (2018) -
Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression
por: Pressler, Heather, et al.
Publicado: (2011) -
Alcohol and Aldehyde Dehydrogenases Contribute to Sex-Related Differences in Clearance of Zolpidem in Rats
por: Peer, Cody J., et al.
Publicado: (2016) -
Materials from peptide assembly: towards the treatment of cancer and transmittable disease
por: Branco, Monica C, et al.
Publicado: (2011)